To access this element change to forms mode OFF
Grant Award View - GA205197
A novel regulator of interferon signalling
GA ID:
GA205197
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
13-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$711,607.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
A novel regulator of interferon signalling
Purpose:
We have identified a new role for a protein called ARAP2 in regulating the immune response to infection. We have generated unique experimental models and have access to immune cells from 25 patients carrying ARAP2 mutations which will enable us to understand the role of ARAP2 in infectious diseases such as TB or Covid-19. This project offers the potential to identify and treat individuals at high risk of life-threatening infections.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011761
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES